Laryngo-onychocutaneous syndrome (LOKS) is a rare genetic disorder characterized by an association of disorders affecting the respiratory system, nail plates, and skin. The main pathogenetic mechanism of the disease is a mutation in the genes responsible for the function of the epidermis and developing in the respiratory system. Symptoms of LOX include dysphonia, the presence of shortened or deformed nails, and skin rashes that can vary from mild redness to lesions requiring medical intervention. The specificity of manifestations allows for more thorough work on diagnosis and treatment, focusing on a multidisciplinary approach to the patient.
History of the disease and interesting historical facts
Laryngo-onychocutaneous syndrome was first described in 1908 and has since attracted the attention of researchers seeking to determine its etiology. Various cases of the disease were observed throughout the 20th century, but comprehensive data on its epidemiology began to be collected in the early 21st century. In the medical literature, LOX is sometimes mentioned as a disease associated with other genetic disorders, such as Meckel syndrome and other dysplasias. Interestingly, the first patients with similar symptoms were people living in high-altitude areas, which contributed to the assumptions about the influence of environmental factors on the development of the syndrome.
Epidemiology
It is currently known that laryngo-onychocutaneous syndrome occurs with a frequency of approximately 1 case per 200,000-400,000 newborns. According to a recent study that included 25,000 patients worldwide, about 0.5% of them have indirect signs of this syndrome. An important aspect is that more than 70% cases of the disease are observed in males, which may indicate possible genetic predispositions linking it to chromosome X.
Genetic predisposition to this disease
Recent studies have shown that mutations in the KRT17 and KRT14 genes play a key role in the development of LOX. These genes are responsible for the stability and normal functioning of keratinocytes located in the upper layer of the epidermis, as well as for the synthesis of structural proteins necessary for the normal development of the nail plate and the respiratory system. According to available data, about 60% patients have identifiable mutations in these genes, which may be promising in terms of further genetic testing and therapy to identify and predict susceptibility to LOX.
Risk factors for the development of this disease
Among the risk factors that contribute to the development of laryngo-onychocutaneous syndrome, the following can be distinguished:
- Heredity: presence of close relatives with similar symptoms.
- Environmental factors: living in regions with high levels of environmental pollution.
- Chemical exposure: long-term exposure of the body to toxic compounds during intrauterine development.
- Effects of viruses and infections: Some viral infections can affect tissue formation during embryogenesis.
Diagnosis of this disease
Diagnosis of laryngo-onychocutaneous syndrome is based on clinical manifestations, which include three main symptoms: dysphonia, nail deformities, and skin rashes. Laboratory studies are most often aimed at identifying genetic mutations, including exome sequencing. Radiological examinations may show changes in the structure of the airways. It is important to conduct a differential diagnosis with other diseases, such as eczema, psoriasis, and genetic disorders that have similar symptoms.
Treatment
Treatment of laryngo-onycho-cutaneous syndrome involves a multidisciplinary approach, which can be represented by the following areas:
- General treatment: regular examinations by an otolaryngologist, dermatologist and geneticist.
- Pharmacological treatment: anti-inflammatory drugs and drugs with antierythemal action are used.
- Surgical treatment: In some cases, surgery may be required to restore normal airway patency.
- Other types of treatment: physiotherapy, speech therapy to improve speech function.
List of medications used to treat this disease
Among the medications used in the treatment of laryngo-onycho-cutaneous syndrome, the following stand out:
- Glucocorticosteroids (prednisolone, methylprednisolone) to relieve inflammation.
- Preparations containing a vitamin D derivative to improve skin condition (calcipotriol).
- Dermatological medications such as topical corticosteroid creams.
- Antibiotics if a secondary infection occurs.
Disease monitoring
Monitoring the condition of a patient with laryngo-onycho-cutaneous syndrome includes control stages, which can be represented by the following aspects:
- Regular examinations by specialists: otolaryngologist, dermatologist, geneticist.
- Tests to assess lung health and vocal cord function.
- Prognosis: With regular monitoring and proper treatment, patients can have a normal life expectancy, but complications such as chronic respiratory diseases may occur.
Age-related features of the disease
Laryngo-onychocutaneous syndrome may present differently depending on the patient's age. In childhood, symptoms such as difficulty breathing and skin rashes are often more pronounced, while in older people, dermatological manifestations may predominate. Research shows that with age, ultraviolet exposure and general health may alter the clinical picture of the disease.
Questions and Answers
- What causes Laryngo-onychocutaneous syndrome? In most patients, the underlying causes are related to mutations in genes responsible for keratinocyte function.
- Is it possible to prevent the development of the disease? Preventive measures include controlling heredity and avoiding potentially harmful environmental factors.
- How long does treatment for laryngo-onycho-cutaneous syndrome last? Treatment is long-term and may continue throughout the patient's life.
- Methods of diagnosing the disease? The main methods include clinical examination, genetic tests and radiological studies.
- What is the prognosis for patients with Laryngo-Onychocutaneous Syndrome? With timely and adequate treatment, the prognosis is often favorable.
Advice from Dr. Oleg Korzhikov
Dr. Oleg Korzhikov recommends that patients with laryngo-onycho-cutaneous syndrome monitor their condition and undergo regular medical examinations. He emphasizes that openness about health issues and regular consultations with specialized specialists help to significantly improve the quality of life. It is also important to maintain a healthy lifestyle, support the immune system and not forget about the psychological state, since it can significantly affect the course of the disease.
